Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10 years ...

Researchers said infrequent zoledronate infusions could be an attractive, lifelong therapy for women at low-risk for fracture ...

Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...

Please provide your email address to receive an email when new articles are posted on . Researchers calculated the likelihood of achieving a BMD T-score of –2.5 or higher with denosumab based on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Postmenopausal, normoglycemic women with a first-degree ...

Talk about not one, but two very expensive malfunctions: 2 BMD-2 armored vehicles fell out of the sky during a drill at the Tsentr-2019 international armed forces exercises, when their parachutes ...

Entera Bio (ENTX) reported new clinical data from a post-hoc analysis of its Phase 2 trial of EB613, at the 2025 North American Menopause Society ...

The Russian MoD has unveiled a plan to launch a large-scale upgrade of the BMD-2 lightweight IFV inventory of the Russian Airborne Troops (VDV) branch, which can be delivered by parachute from Il-76 ...

Although bone mineral density (BMD) testing to screen for osteoporosis (BMD T score, −2.50 or lower) is recommended for women 65 years of age or older, there are few data to guide decisions about the ...

Persons with Down syndrome (DS) have shown diminished levels of bone mass compared with those without DS; [1–4] therefore, DS population might be considered as a population at higher risk of suffering ...

The BMD-2M air-deployable infantry fighting vehicle (IFV) has entered state trials with the Russian Airborne Troops (VDV), the TASS news agency reported on 31 July, citing Russian defence industry ...